NCT02468583View on ClinicalTrials.gov

Proof of Concept Study Comparing FX006 to Kenalog®-40 in Patients With Post-Traumatic Osteoarthritis of the Knee

PHASE2TerminatedINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

February 28, 2015

Primary Completion Date

July 31, 2016

Study Completion Date

July 31, 2016

Conditions
Post-traumatic Osteoarthritis of the Knee
Interventions
DRUG

FX006 32 mg

Experimental

DRUG

TCA IR 40 mg

Comparator

Trial Locations (1)

78234

San Antonio Military Medical Center, San Antonio

Sponsors
All Listed Sponsors
lead

Pacira Pharmaceuticals, Inc

INDUSTRY